As spring rolls into summer, covered entities find themselves in a holding pattern on many items related to 340B, waiting to see how things will shake out. This month, we cover updates and review news-yet-to-come on issues including new drug pricing legislation, the ongoing lawsuit against HHS, the proposed new IPI payment model, possible cuts to Medicare Part D, and more.
Leaders shared the challenges health systems face in the specialty pharmacy space, how to manage payer negotiations and other operational pearls of wisdom for health systems.
Sentry Data Systems recently sponsored and attended two spring conferences with a focus on rural healthcare – the Texas Organization of Rural and Community Hospitals (TORCH) Annual Conference and Trade Show held in April in Dallas, and the National Rural Health Association (NRHA) Annual Conference held in May in Atlanta.
In this month’s 340Buzz: The administration looks to 340B to help tackle the HIV epidemic; Apexus releases updates to its FAQs; HRSA releases an update about ceiling prices; 340B legislation springs up at the state level; judge makes additional ruling on 340B reimbursement cuts.
Sentry was pleased to have the opportunity to engage with hospital finance leaders on topics spanning both 340B and analytics and dive deeper into healthcare’s most pressing challenges and more importantly, the solutions.
One often overlooked consideration when selecting a technology vendor is the implementation process. An ideal implementation is one with open communication, efficient processes and rapid time-to-value.
HRSA launches the long-awaited 340B drug ceiling prices website, two new bills that would affect 340B are proposed in the House, and the government begins to examine 340B rebates for Medicare Part D drugs.
Sentry Data Systems recently sponsored and attended the Texas Hospital Association (THA) Annual Conference and Expo, held February 20-22 in Austin, Texas. Sentry was pleased to have the opportunity to engage with hospitals on topics spanning both 340B and analytics.
APhA convenes annually to address key policy areas impacting pharmacists through the APhA House of Delegates (HOD). The HOD has membership from many pharmacy associations, including the American Health-System Pharmacists, American College of Clinical Pharmacy, and American Managed Care Pharmacy.
HHS appeals the court’s recent decision regarding the Part B reimbursement cuts; the administration announces its 2020 budget, which includes several 340B initiatives; an executive order in California could put the program in jeopardy; a new bill focused on rural hospitals is introduced in the House; and a report from Drug Channels Institute touches on 340B.